Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
CALL
Ascendis Pharma A/S
ASND
$16.8B
| $2.83M | ﹤0.01% |
+22,500
| New | +$2.24M |
|
|
2577
PUT
Ascendis Pharma A/S
ASND
$16.8B
| $2.83M | ﹤0.01% |
+22,500
| New | +$2.24M |
|
2578
Editas Medicine
EDIT
$442M
| $2.83M | ﹤0.01% |
279,437
+4,421
| +2% | +$38.8K |
|
2579
PUT
EQT Corp
EQT
$32.3B
| $2.83M | ﹤0.01% |
+73,200
| New | +$2.97M |
|
2580
Hillman Solutions
HLMN
$1.79B
| $2.83M | ﹤0.01% |
307,060
+236,854
| +337% | +$1.81M |
|
2581
ACM Research
ACMR
$5.79B
| $2.82M | ﹤0.01% |
144,452
+59,986
| +71% | +$1.05M |
|
2582
MGP Ingredients
MGPI
$375M
| $2.81M | ﹤0.01% |
28,559
+20,424
| +251% | +$1.96M |
|
2583
InvenTrust Properties
IVT
$2.59B
| $2.81M | ﹤0.01% |
110,981
+84,649
| +321% | +$2.11M |
|
2584
Chewy
CHWY
$9.63B
| $2.81M | ﹤0.01% |
118,946
-252,518
| -68% | -$4.98M |
|
2585
John Wiley & Sons Class A
WLY
$2.66B
| $2.81M | ﹤0.01% |
88,465
+53,238
| +151% | +$1.67M |
|
2586
Sabre
SABR
$835M
| $2.81M | ﹤0.01% |
637,863
+341,375
| +115% | +$1.32M |
|
|
HCP
2587
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $2.8M | ﹤0.01% |
118,422
+68,790
| +139% | +$1.49M |
|
2588
Navient
NAVI
$853M
| $2.79M | ﹤0.01% |
150,037
+73,271
| +95% | +$1.28M |
|
2589
Carter's
CRI
$1.47B
| $2.79M | ﹤0.01% |
37,280
+16,467
| +79% | +$1.14M |
|
2590
PUT
Unisys
UIS
$217M
| $2.79M | ﹤0.01% |
+496,100
| New | +$2.11M |
|
2591
Rocket Lab Corp
RKLB
$51.8B
| $2.79M | ﹤0.01% |
503,648
+377,066
| +298% | +$1.7M |
|
2592
PUT
Illumina
ILMN
$28.4B
| $2.78M | ﹤0.01% |
+20,560
| New | +$2.37M |
|
2593
CALL
Ionis Pharmaceuticals
IONS
$9.4B
| $2.78M | ﹤0.01% |
55,000
-5,000
| -8% | -$239K |
|
|
2594
PUT
Ionis Pharmaceuticals
IONS
$9.4B
| $2.78M | ﹤0.01% |
+55,000
| New | +$2.63M |
|
2595
Vicor
VICR
$10.2B
| $2.78M | ﹤0.01% |
61,904
+46,945
| +314% | +$2.07M |
|
2596
Hawkins
HWKN
$2.71B
| $2.77M | ﹤0.01% |
39,405
+24,570
| +166% | +$1.53M |
|
2597
Stock Yards Bancorp
SYBT
$2.6B
| $2.77M | ﹤0.01% |
53,753
+23,833
| +80% | +$1.06M |
|
|
2598
PUT
CRH
CRH
$66.8B
| $2.77M | ﹤0.01% |
+40,000
| New | +$2.41M |
|
|
WSR
2599
DELISTED
Whitestone REIT
WSR
| $2.76M | ﹤0.01% |
224,796
+4,244
| +2% | +$45.5K |
|
2600
Eldorado Gold
EGO
$9.89B
| $2.76M | ﹤0.01% |
212,713
+165,367
| +349% | +$1.86M |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.